New ASCO data highlight presurgical ctDNA as a relapse predictor in early NSCLC and show surgery improves survival over radiation among veterans.
The post Early NSCLC at ASCO: Evaluating New Assay & Treatment Patterns first appeared on Physician’s Weekly.
